comparemela.com

Latest Breaking News On - மலேரியா துணிகர - Page 4 : comparemela.com

GHTC joins statement to the World Health Assembly on the global malaria strategy

GHTC joins statement to the World Health Assembly on the global malaria strategy The following statement from Medicines for Malaria Venture and PATH, supported by the Global Health Technologies Coalition, Foundation for Innovative New Diagnostics, and Innovative Vector Control Consortium was submitted to the 74 th World Health Assembly on agenda item 34.1: Progress reports, including the Global Technical Strategy for Malaria 2016–2030. Our organizations, bringing together academia, industry and access partners, are devoted to developing and facilitating access to life-saving malaria prevention tools, diagnostics and medicines. Since the launch of the WHO Strategy, several innovations have helped transform the prevention and treatment of malaria, and saved millions of lives. These innovations include:

Positron emission tomography and magnetic resonance imaging in experimental human malaria to identify organ-specific changes in morphology and glucose metabolism: A prospective cohort study

Research Article Positron emission tomography and magnetic resonance imaging in experimental human malaria to identify organ-specific changes in morphology and glucose metabolism: A prospective cohort study John Woodford , Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Writing – original draft, Writing – review & editing Affiliation Commonwealth Scientific and Industrial Research Organisation, Brisbane, Australia Jennie Roberts, Roles Investigation, Project administration, Writing – review & editing Affiliations Clinical Tropical Medicine Laboratory, QIMR-Berghofer Medical Research Institute, Brisbane, Australia, Centre for Defence Pathology, Royal Centre for Defence Medicine, Birmingham, United Kingdom Roles Project administration, Supervision, Writing – review & editing Affiliatio

Merck donates anti-malarial candidate

Merck donates anti-malarial candidate Merck & Co has announced a licensing agreement with Medicines for Malaria Venture for an investigational drug against malaria for use in the developing world Merck & Co has announced a licensing agreement with Medicines for Malaria Venture (MMV) for an investigational drug against malaria for use in the developing world . Under the agreement, Merck, whose researchers discovered the candidate, has granted MMV an exclusive, royalty-free licence to develop it for use in malaria-endemic countries. MMV is a not-for-profit virtual research and development organisation. Merck retains the option to become MMV s development partner upon completion of the first Phase II clinical trial, but has committed not to profit ultimately from its use in developing countries.

TRIBUTE | Former Swiss Ambassador Dr Konji Sebati: The embodiment of selflessness, sacrifice

TRIBUTE | Former Swiss Ambassador Dr Konji Sebati: The embodiment of selflessness, sacrifice
news24.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news24.com Daily Mail and Mail on Sunday newspapers.

Novartis reaches milestone delivery of 1 billion courses of antimalarial treatment

Novartis reaches milestone delivery of 1 billion courses of antimalarial treatment
socialnews.xyz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from socialnews.xyz Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.